Works about PIOGLITAZONE
Results: 963
Management of elevated blood glucose in type 2 diabetes.
- Published in:
- Practice Nursing, 2019, v. 30, n. 1, p. 32, doi. 10.12968/pnur.2019.30.1.32
- By:
- Publication type:
- Article
Managing problems with medications for type 2 diabetes.
- Published in:
- Practice Nursing, 2017, v. 28, n. 4, p. 148, doi. 10.12968/pnur.2017.28.4.148
- By:
- Publication type:
- Article
The link between diabetes and polycystic ovary syndrome.
- Published in:
- Practice Nursing, 2013, v. 24, n. 3, p. 120, doi. 10.12968/pnur.2013.24.3.120
- By:
- Publication type:
- Article
Managing diabetes during the holy month of Ramadan.
- Published in:
- Practice Nursing, 2012, v. 23, n. 6, p. 302, doi. 10.12968/pnur.2012.23.6.302
- By:
- Publication type:
- Article
What is the role of pioglitazone for patients with type 2 diabetes in value-based care settings?
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 3, p. 131, doi. 10.1007/s40267-024-01052-1
- By:
- Publication type:
- Article
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 2, p. 103, doi. 10.1002/hup.2517
- By:
- Publication type:
- Article
Pioglitazone reduces urinary albumin excretion in renin−angiotensin system inhibitor-treated type 2 diabetic patients with hypertension and microalbuminuria: the APRIME study.
- Published in:
- Clinical & Experimental Nephrology, 2011, v. 15, n. 6, p. 848, doi. 10.1007/s10157-011-0512-3
- By:
- Publication type:
- Article
Risk of Stroke with Thiazolidinediones: A Ten-Year Nationwide Population-Based Cohort Study.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 145, doi. 10.1159/000353679
- By:
- Publication type:
- Article
The Capsular Warning Syndrome Reconsidered.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 152, doi. 10.1159/000352045
- By:
- Publication type:
- Article
Hypertrophic Olivary Degeneration after Pontine Hemorrhage: A Cause of Delayed Neurological Deterioration.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 153, doi. 10.1159/000352063
- By:
- Publication type:
- Article
Rapid Progression of Unilateral Moyamoya Disease in a Patient with a Family History and an RNF213 Risk Variant.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 155, doi. 10.1159/000352065
- By:
- Publication type:
- Article
Reversible Cerebral Vasoconstriction Syndrome after Chewing Khat Leaves.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 158, doi. 10.1159/000353664
- By:
- Publication type:
- Article
ESO News.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 160, doi. 10.1159/000355578
- By:
- Publication type:
- Article
Computational Evaluation on Molecular Structure, Charge, NMR, Electronic (HOMO-LUMO) Properties, and Spectroscopic Profiling of Pioglitazone with Molecular Docking Studies.
- Published in:
- Trends in Sciences, 2022, v. 19, n. 24, p. 1, doi. 10.48048/tis.2022.2872
- By:
- Publication type:
- Article
The Efficacy of Adding Pioglitazone to Insulin Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis.
- Published in:
- Journal of Pharmacoeconomics & Pharmaceutical Management, 2021, v. 7, n. 1/2, p. 3
- By:
- Publication type:
- Article
Comparison of the Effect of Pioglitazone and Metformin on HOMA IR In Patient of Prediabetes.
- Published in:
- Indian Journal of Basic & Applied Medical Research, 2021, v. 10, n. 3, p. 43, doi. 10.36848/IJBAMR/2020/29215.55575
- By:
- Publication type:
- Article
Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 18, p. 1411, doi. 10.1093/jnci/djs328
- By:
- Publication type:
- Article
Correction: A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus.
- Published in:
- Egyptian Journal of Internal Medicine, 2024, v. 36, n. 1, p. 1, doi. 10.1186/s43162-024-00302-y
- By:
- Publication type:
- Article
A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus.
- Published in:
- Egyptian Journal of Internal Medicine, 2024, v. 36, n. 1, p. 1, doi. 10.1186/s43162-023-00269-2
- By:
- Publication type:
- Article
Prescribing pearls: A guide to pioglitazone.
- Published in:
- Diabetes & Primary Care, 2024, v. 26, n. 5, p. 169
- By:
- Publication type:
- Article
ADA from home!
- Published in:
- Diabetes & Primary Care, 2020, v. 22, n. 4, p. 75
- By:
- Publication type:
- Article
A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe.
- Published in:
- Diabetes & Primary Care, 2020, v. 22, n. 3, p. 1
- By:
- Publication type:
- Article
The Primary Care Diabetes Society's response to NICE on the draft type 2 diabetes guideline.
- Published in:
- Diabetes & Primary Care, 2015, v. 17, n. 2, p. 67
- By:
- Publication type:
- Article
Evidence-based medicine. Part 5: Observational evidence.
- Published in:
- Diabetes & Primary Care, 2011, v. 13, n. 5, p. 284
- By:
- Publication type:
- Article
Pioglitazone and bladder cancer: PCDS statement.
- Published in:
- Diabetes & Primary Care, 2011, v. 13, n. 4, p. 202
- Publication type:
- Article
Pioglitazone: Balancing risks and benefits.
- Published in:
- Diabetes & Primary Care, 2011, v. 13, n. 4, p. 199
- By:
- Publication type:
- Article
Determination of Rosiglitazone by Direct Analysis in Real-Time Mass Spectrometry.
- Published in:
- Analytical Letters, 2017, v. 50, n. 11, p. 1721, doi. 10.1080/00032719.2016.1248245
- By:
- Publication type:
- Article
Effect and mechanism of Danzhi Jiangtang Capsule on diabetic angiogenesis through regulatingVEGF signaling pathway.
- Published in:
- Journal of Beijing University of Traditional Chinese Medicine, 2020, v. 43, n. 2, p. 141, doi. 10.3969/j.issn.1006-2157.2020.02.008
- By:
- Publication type:
- Article
Pioglitazone as a Possible Treatment for Ataxia-Telangiectasia.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 10, p. 1264, doi. 10.3390/biom14101264
- By:
- Publication type:
- Article
Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 8, p. 1199, doi. 10.3390/biom13081199
- By:
- Publication type:
- Article
Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 2, p. 281, doi. 10.3390/biom12020281
- By:
- Publication type:
- Article
Retrospective Observational Dose-Titration Study of Subjects with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on 15 mg of Pioglitazone.
- Published in:
- Journal of Korean Diabetes, 2016, v. 17, n. 1, p. 51, doi. 10.4093/jkd.2016.17.1.51
- By:
- Publication type:
- Article
Do antidiabetic drugs prevent the transformation of Acanthamoeba trophozoite into cyst form?
- Published in:
- Pathogens & Global Health, 2023, v. 117, n. 7, p. 674, doi. 10.1080/20477724.2022.2151859
- By:
- Publication type:
- Article
Banting memorial lecture 2022: 'Type 2 diabetes and nonalcoholic fatty liver disease: Partners in crime'.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 10, p. 1, doi. 10.1111/dme.14912
- Publication type:
- Article
Pioglitazone and bladder cancer: improving research methods.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 2, p. 194, doi. 10.1111/dme.14179
- By:
- Publication type:
- Article
Pioglitazone: inexpensive; very effective at reducing HbA<sub>1c</sub>; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 9, p. 1185, doi. 10.1111/dme.14053
- By:
- Publication type:
- Article
A systematic review of observational studies of the association between pioglitazone use and bladder cancer.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 1, p. 22, doi. 10.1111/dme.13854
- By:
- Publication type:
- Article
Combination therapy with multiple oral hypoglycaemic agents together with short-term basal insulin in new-onset Type 2 diabetes mellitus with marked hyperglycaemia.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 9, p. 1322, doi. 10.1111/dme.13393
- By:
- Publication type:
- Article
Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 2, p. 180, doi. 10.1111/dme.13125
- By:
- Publication type:
- Article
Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA<sub>1c</sub> and high incidence of hypoglycaemia.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 9, p. e17, doi. 10.1111/dme.12988
- By:
- Publication type:
- Article
Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 7, p. 926, doi. 10.1111/dme.13041
- By:
- Publication type:
- Article
NICE guidelines for Type 2 diabetes: revised but still not fit for purpose.
- Published in:
- Diabetic Medicine, 2015, v. 32, n. 11, p. 1398, doi. 10.1111/dme.12952
- By:
- Publication type:
- Article
Pioglitazone: reports of its death are greatly exaggerated.
- Published in:
- Diabetic Medicine, 2015, v. 32, n. 4, p. e9, doi. 10.1111/dme.12736
- By:
- Publication type:
- Article
Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter.
- Published in:
- Diabetic Medicine, 2015, v. 32, n. 4, p. 438, doi. 10.1111/dme.12703
- By:
- Publication type:
- Article
Pioglitazone: are rumours of its death exaggerated?
- Published in:
- Diabetic Medicine, 2015, v. 32, n. 4, p. 431, doi. 10.1111/dme.12708
- By:
- Publication type:
- Article
Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit.
- Published in:
- Diabetic Medicine, 2015, v. 32, n. 3, p. 305, doi. 10.1111/dme.12627
- By:
- Publication type:
- Article
Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study.
- Published in:
- Diabetic Medicine, 2014, v. 31, n. 12, p. 1505, doi. 10.1111/dme.12495
- By:
- Publication type:
- Article
Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2014, v. 31, n. 11, p. 1341, doi. 10.1111/dme.12481
- By:
- Publication type:
- Article
Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 9, p. 1026, doi. 10.1111/dme.12144
- By:
- Publication type:
- Article